Fig. 6From: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MDA comparison of the systemic exposure (AUC) of a poorly soluble selective glucocorticoid modulator (SGRM) and the predicted total lung dose for six different devices and formulations (number of healthy volunteers ranging between 12 and 18). (From (Olsson & Bäckman 2014))Back to article page